Pharmaceutical composition comprising solid dispersion of BCS class II drugs with Gelucires
US10952966B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2017 |
| Grant date | Mar 23, 2021 |
| Priority date | — |
| Expiry date | Jan 6, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4184
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A solid pharmaceutical composition comprising a solid dispersion of a BCS Class II drug in a solid carrier/hydrophilic carrier; and a pH modifier. The solid carrier/hydrophilic carrier has a melting point of between about 40° C. to about 60° C. and an HLB value of between about 10 and about 18. The BCS Class II drug may be telmisartan.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.